Pharmaceutical Intermediates Atomoxetine HCl Powder API Atomoxetine Hydrochloride Powder Purity Atomoxetine

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Atomoxetine
• Product Name: Atomoxetine
• Name: Atomoxetine Powder
• Appearance: off-White to White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediates
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 83015-26-3
• Mf: C17h21no
• MW: 255.361
• Density: 1.023
• Boiling Point: 389 C at 760 Mmhg
• Refractive Index: 1.552
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 2 Ton/Month

Product Description

Pharmaceutical Intermediates Atomoxetine Hcl Powder API Atomoxetine Hydrochloride Powder Purity Atomoxetine

 

Product Description

Product Details

Product Name	Atomoxetine
CAS No.	83015-26-3
MF	C17H21NO
MW	255.361
Appearance and shape	Off-white to White powder

Atomoxetine hydrochloride is the hydrochloride form of atomoxetine, a drug used for the nervous system, and belongs to an adrenergic transmitter reuptake inhibitor, used to treat inattention and hyperactivity. Tomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) whose structure is similar to fluoxetine.
Atomoxetine hydrochloride is the first stimulant drug approved by the to treat attention deficit disorder with hyperactivity (ADHD). It has not been found in clinical trials to cause other stimulant drugs or cause euphoria drugs. . Randomized, placebo-controlled trials in children and adults have confirmed that the product can effectively treat ADHD.

Application & Function

1. The precise mechanism of tomoxetine hydrochloride for the treatment of pediatric ADHD is unclear. It is currently believed that the therapeutic effects of this product are related to other selective inhibition of the reuptake effect of presynaptic amine pumps on norepinephrine, which enhances the flipping effect of norepinephrine, thereby improving the symptoms of pediatric ADHD and indirectly promoting the completion of cognition and concentration.
2. Tomoxetine hydrochloride is indicated for the treatment of ADHD in children and adolescents.

Specification